FDA Approves Second West Nile Virus Test
Posted on: Wednesday, 29 August 2007, 09:17 CDT
The U.S. Food and Drug Administration has approved a second screening test for West Nile Virus disease for use in donated blood and organs.
The cobas TaqScreen WNV test is an automated test that's able to detect the genetic material of the virus itself early during the infection process, the FDA said. The nucleic acid testing detects whether donated blood and organs have been infected, even if the donor's body hasn't begun to produce antibodies against the virus.
West Nile Virus is most often transmitted to humans by mosquitoes but it can also be transmitted through blood transfusion or organ transplantation from infected donors.
The approval means blood centers and hospitals will have a choice of two FDA-approved tests, said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research.
The newly approved test is manufactured by Roche Molecular Systems Inc. of Pleasanton, Calif.
Source: United Press International
Related Articles
- FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
- Corgenix AspirinWorks(R) Test Kit Cleared By FDA
- Roche Diagnostics Submits West Nile Virus Blood Screening Test to FDA
- Ethicists Blast Study Testing Fake Blood
- Leavenworth County, Kan.M Approves Testing Synthetic Blood
- Bird Flu Test Receives Federal Approval
- Gen-Probe Receives FDA Approval for PROCLEIX(R) West Nile Virus Blood Screening Assay
- Kansas Counties to Test Synthetic Blood
- Pfizer Seeking Cancer Drug Approval ; FDA Filing Marks Attempt to Lead in Oncology
- 2 Utah Hospitals to Test Artificial Blood
 |
 |
User Comments (0)
RSS Feeds